Literature DB >> 19175391

Blood-brain barrier damage and brain penetration of antiepileptic drugs: role of serum proteins and brain edema.

Nicola Marchi1, Giulia Betto, Vincent Fazio, Quinyuan Fan, Chaitali Ghosh, Andre Machado, Damir Janigro.   

Abstract

PURPOSE: Increased blood-brain barrier (BBB) permeability is radiologically detectable in regions affected by drug-resistant epileptogenic lesions. Brain penetration of antiepileptic drugs (AEDs) may be affected by BBB damage. We studied the effects of BBB damage on brain distribution of hydrophilic [deoxy-glucose (DOG) and sucrose] and lipophilic (phenytoin and diazepam) molecules. We tested the hypothesis that lipophilic and hydrophilic drug distribution is differentially affected by BBB damage.
METHODS: In vivo BBB disruption (BBBD) was performed in rats by intracarotid injection of hyperosmotic mannitol. Drugs (H3-sucrose, 3H-deoxy-glucose, 14C-phenytoin, and C14-diazepam) or unlabeled phenytoin was measured and correlated to brain water content and protein extravasation. In vitro hippocampal slices were exposed to different osmolarities; drug penetration and water content were assessed by analytic and densitometric methods, respectively.
RESULTS: BBBD resulted in extravasation of serum protein and radiolabeled drugs, but was associated with no significant change in brain water. Large shifts in water content in brain slices in vitro caused a small effect on drug penetration. In both cases, total drug permeability increase was greater for lipophilic than hydrophilic compounds. BBBD reduced the amount of free phenytoin in the brain. DISCUSSION: After BBBD, drug binding to protein is the main controller of total brain drug accumulation. Osmotic BBBD increased serum protein extravasation and reduced free phenytoin brain levels. These results underlie the importance of brain environment and BBB integrity in determining drug distribution to the brain. If confirmed in drug-resistant models, these mechanisms could contribute to drug brain distribution in refractory epilepsies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19175391      PMCID: PMC2824251          DOI: 10.1111/j.1528-1167.2008.01989.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  52 in total

1.  Focal cortical dysfunction and blood-brain barrier disruption in patients with Postconcussion syndrome.

Authors:  Akira Korn; Haim Golan; Israel Melamed; Roberto Pascual-Marqui; Alon Friedman
Journal:  J Clin Neurophysiol       Date:  2005 Jan-Feb       Impact factor: 2.177

Review 2.  Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means.

Authors:  R A Kroll; E A Neuwelt
Journal:  Neurosurgery       Date:  1998-05       Impact factor: 4.654

3.  Chloroquine administration in mice increases beta-amyloid immunoreactivity and attenuates kainate-induced blood-brain barrier dysfunction.

Authors:  J G Mielke; M P Murphy; J Maritz; K M Bengualid; G O Ivy
Journal:  Neurosci Lett       Date:  1997-05-23       Impact factor: 3.046

4.  Development of hippocampal atrophy: a serial magnetic resonance imaging study in a patient who developed epilepsy after generalized status epilepticus.

Authors:  U C Wieshmann; F G Woermann; L Lemieux; S L Free; P A Bartlett; S J Smith; J S Duncan; J M Stevens; S D Shorvon
Journal:  Epilepsia       Date:  1997-11       Impact factor: 5.864

5.  Breakdown of the blood-brain barrier to proteins in white matter of the developing brain following systemic inflammation.

Authors:  H B Stolp; K M Dziegielewska; C J Ek; M D Habgood; M A Lane; A M Potter; N R Saunders
Journal:  Cell Tissue Res       Date:  2005-04-22       Impact factor: 5.249

6.  Acute 3-nitropropionic acid intoxication induces striatal astrocytic cell death and dysfunction of the blood-brain barrier: involvement of dopamine toxicity.

Authors:  H Nishino; M Kumazaki; A Fukuda; I Fujimoto; Y Shimano; H Hida; T Sakurai; S B Deshpande; H Shimizu; S Morikawa; T Inubushi
Journal:  Neurosci Res       Date:  1997-04       Impact factor: 3.304

7.  Heparin oligosaccharides that pass the blood-brain barrier inhibit beta-amyloid precursor protein secretion and heparin binding to beta-amyloid peptide.

Authors:  B Leveugle; W Ding; F Laurence; M P Dehouck; A Scanameo; R Cecchelli; H Fillit
Journal:  J Neurochem       Date:  1998-02       Impact factor: 5.372

Review 8.  Drug resistance in brain diseases and the role of drug efflux transporters.

Authors:  Wolfgang Löscher; Heidrun Potschka
Journal:  Nat Rev Neurosci       Date:  2005-08       Impact factor: 34.870

9.  Interictal seizure resections show two configurations of endothelial Glut1 glucose transporter in the human blood-brain barrier.

Authors:  E M Cornford; S Hyman; M E Cornford; E M Landaw; A V Delgado-Escueta
Journal:  J Cereb Blood Flow Metab       Date:  1998-01       Impact factor: 6.200

Review 10.  Drug bioactivation, covalent binding to target proteins and toxicity relevance.

Authors:  Shufeng Zhou; Eli Chan; Wei Duan; Min Huang; Yu-Zong Chen
Journal:  Drug Metab Rev       Date:  2005       Impact factor: 4.518

View more
  30 in total

Review 1.  Transporters in drug-refractory epilepsy: clinical significance.

Authors:  N Marchi; J Gonzalez-Martinez; M-T Nguyen; T Granata; D Janigro
Journal:  Clin Pharmacol Ther       Date:  2010-01       Impact factor: 6.875

2.  The 3D Brain Unit Network Model to Study Spatial Brain Drug Exposure under Healthy and Pathological Conditions.

Authors:  Esmée Vendel; Vivi Rottschäfer; Elizabeth C M de Lange
Journal:  Pharm Res       Date:  2020-07-09       Impact factor: 4.200

Review 3.  Blood-brain barrier, bulk flow, and interstitial clearance in epilepsy.

Authors:  Nicola Marchi; Manoj Banjara; Damir Janigro
Journal:  J Neurosci Methods       Date:  2015-06-18       Impact factor: 2.390

Review 4.  Management of the patient with medically refractory epilepsy.

Authors:  Tiziana Granata; Nicola Marchi; Erin Carlton; Chaitali Ghosh; Jorge Gonzalez-Martinez; Andreas V Alexopoulos; Damir Janigro
Journal:  Expert Rev Neurother       Date:  2009-12       Impact factor: 4.618

5.  Multimodal investigations of trans-endothelial cell trafficking under condition of disrupted blood-brain barrier integrity.

Authors:  Nicola Marchi; Qingshan Teng; Minh T Nguyen; Linda Franic; Nirav K Desai; Thomas Masaryk; Peter Rasmussen; Silvia Trasciatti; Damir Janigro
Journal:  BMC Neurosci       Date:  2010-03-09       Impact factor: 3.288

6.  Heat Shock Proteins Accelerate the Maturation of Brain Endothelial Cell Glucocorticoid Receptor in Focal Human Drug-Resistant Epilepsy.

Authors:  Mohammed Hossain; Sherice Williams; Lisa Ferguson; William Bingaman; Arnab Ghosh; Imad M Najm; Chaitali Ghosh
Journal:  Mol Neurobiol       Date:  2020-08-03       Impact factor: 5.590

7.  Circulating angiotensin II gains access to the hypothalamus and brain stem during hypertension via breakdown of the blood-brain barrier.

Authors:  Vinicia Campana Biancardi; Sook Jin Son; Sahra Ahmadi; Jessica A Filosa; Javier E Stern
Journal:  Hypertension       Date:  2013-12-16       Impact factor: 10.190

Review 8.  Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system.

Authors:  Andrea Calcagno; Giovanni Di Perri; Stefano Bonora
Journal:  Clin Pharmacokinet       Date:  2014-10       Impact factor: 6.447

9.  Fixed negative charge and the Donnan effect: a description of the driving forces associated with brain tissue swelling and oedema.

Authors:  Benjamin S Elkin; Mohammed A Shaik; Barclay Morrison
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2010-02-13       Impact factor: 4.226

10.  Small vessel ischemic disease of the brain and brain metastases in lung cancer patients.

Authors:  Peter J Mazzone; Nicola Marchi; Vince Fazio; J Michael Taylor; Thomas Masaryk; Luke Bury; Tarek Mekhail; Damir Janigro
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.